x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Green Rush

The Green Rush is real. From lawmakers and investment bankers, to CEOs and investors, we will look at how people are transforming cannabis from the shadows of the illicit market into a cash crop that draws in entrepreneurs from Hollywood to Wall Street. Hosts Lewis Goldberg and Anne Donohoe help you navigate the business of cannabis.

news business news

All Episodes

54:10

Netflix’s ‘Have a Good Trip’ Director Donick Cary...

The Green Rush ·

2024/07/25

This summer, we are revisiting our extensive archives, curating a selection from over 300 past episodes. This collection will feature memorable moments, insightful interviews, and some of the team's favorite episodes, providing new listeners and long-time fans an opportunity to explore or rediscover the best of Green Rush. Stay tuned for the upcoming launch of our new podcast in the fall, "Alternatively Speaking."This week, we're bringing back our conversation with Emmy-winning Writer, Producer,

en-US

48:30

Jarrett Annenberg, SVP and Head of Investments,...

The Green Rush ·

2024/07/18

Overview:In this episode of The Green Rush, Anne Donohoe and Lewis Goldberg sit down with Jarrett Annenberg, Senior Vice President and Head of Investments at NewLake Capital Partners, to explore the complexities and opportunities in cannabis real estate. Jarrett shares insights into the challenges and strategies of navigating the cannabis industry, the impact of the potential rescheduling of cannabis, and the future of cannabis real estate investments. NewLake Capital Partners (OTCQX: NLCP) is an

en-US

36:33

James Krouse, CEO of Flower Power Genetics

The Green Rush ·

2024/06/20

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.This week, Anne Donohoe sat down with James Krouse, CEO of Flower Power Genetics, to talk about how his company is working to preserve and reintroduce the best purebred medicinal cannabis strains into the marketplace. James walked our host through his past 30 years of work including how he has painstakingly researched,

en-US

39:05

Gibran Washington, CEO of ETHOS Cannabis

The Green Rush ·

2024/06/13

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.This week, Anne Donohoe sat down with Gibran Washington, CEO of ETHOS Cannabis, a medical forward multi-state operator with operations in Pennsylvania, Massachusetts and Ohio. In today’s conversation, Gibran opens up to Anne about his journey from corporate America to cannabis and how life lessons learned at a young age from

en-US

40:08

Tim Pickett, CEO of KindlyMD

The Green Rush ·

2024/06/06

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.This week Anne Donohoe sits down with Tim Pickett, CEO of KindlyMD, a patient-first healthcare and healthcare data company uniquely integrating traditional primary care with medicinal cannabis. In our conversation, Anne and Tim explore his professional evolution from being a board-certified physician assistant to founding a

en-US

1:03:26

Paul Armentano, Deputy Director of NORML

The Green Rush ·

2024/05/30

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.This week Anne Donohoe and Kris Krane are back to sit down with Paul Armentano, Deputy Director of NORML. Paul joined our hosts this week to talk about his career of advocacy work within the cannabis space and to highlight the positives and shortcomings with the DEA’s proposed move to reschedule cannabis. Paul walked us through

en-US

30:11

Revisiting Our Conversation with Dr. Hans Eriksson,...

The Green Rush ·

2024/05/23

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.This week we wanted to revisit our conversation with special guest Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health. Hans joined us to discuss his role at HMNC, the company’s research and development efforts to identify and bring to market treatments for mental health disorders, and the latest news and progress on

en-US

52:35

MAPS Roundtable on DEA Rescheduling of Cannabis

The Green Rush ·

2024/05/16

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week’s episode is a crossover roundtable event with our friends at the Multidisciplinary Association for Psychedelic Studies (MAPS) covering the DEA’s proposed rescheduling of cannabis from Schedule I to a Schedule III drug. Hosted by our very own Anne Donohoe, the Q&A discussion also features Betty Aldworth, Director of

en-US

56:35

Adam Smith, Founder of Alliance for Sensible Markets

The Green Rush ·

2024/05/09

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week Lewis Goldberg and Kris Krane sit down with long-time friend of the podcast Adam Smith, Founder and President of the Alliance for Sensible Markets, to talk about the DEA’s historic decision to reclassify cannabis from a Schedule I to Schedule III drug. As a long-time advocate working behind the scenes for decades to

en-US

42:42

Ian Dominguez, Founder & CIO, Delta Emerald Ventures

The Green Rush ·

2024/04/25

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week hosts Anne and Phil speak with Ian Dominguez, founder and CIO of Delta Emerald Ventures, a leader in intelligent cannabis investing and industry insight. Ian joins Anne and Phil to talk about the booming market in hemp-derived products, including the growing drinks category, industry consolidation, and the conditions

en-US

40:47

Revisiting Ric Flair, Hall-of-Fame Wrestler & Founder...

The Green Rush ·

2024/04/11

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Lewis Goldberg is back for a revisited episode with special guest Ric Flair, Hall-of-Fame wrestler and Founder of Ric Flair Drip, a cannabis brand that offers flower, pre-rolls, edibles and more. Ric joins us this week to discuss his wrestling experiences and perspective on the industry, the parallels of wrestling and

en-US

50:58

Socrates Rosenfeld, CEO & Co-Founder, Jane Technologies

The Green Rush ·

2024/04/04

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Phil Carlson and Anne Donohoe talk to Socrates Rosenfeld, CEO and Co-Founder of Jane Technologies. Socrates joins us to discuss his experience in the US Army, having never touched cannabis, and the journey which led to the birth of Jane Technologies and its unique vision on how consumers want to shop. In this

en-US

48:22

Michelle Minton & Geoffrey Lawrence, Reason Foundation

The Green Rush ·

2024/03/21

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Phil Carlson talk to Reason Foundation’s Senior Policy Analyst Michelle Minton and Research Director Geoffrey Lawrence. Michelle and Geoff join us to discuss their drug policy work at Reason Foundation, their latest projects at the organization and their respective journeys to Reason. In this episode,

en-US

33:24

Dr. Joe Tucker, CEO of Enveric Biosciences (NASDAQ:...

The Green Rush ·

2024/02/29

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich talk to Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogen therapeutics for the treatment of neuropsychiatric disorders. Dr. Tucker joins us to discuss the latest news and milestones for the company,

en-US

34 results

Similar Podcasts

DW Noticias

DW

JIJI English News-時事通信英語ニュース-

時事通信社

Legal AF by MeidasTouch

MeidasTouch Network

Mark Levin Podcast

Cumulus Podcast Network

朝日新聞AJW 英語ニュース（The Asahi Shimbun Asia & Japan Watch）

朝日新聞ポッドキャスト